Fluress

Active Ingredient(s): Benoxinate + Fluorescein
Category: Anesthetic



Fluress Overview

Oxybuprocaine (INN), also known as benoxinate or BNX, is an ester-type local anesthetic, which is used especially in ophthalmology and otolaryngology. Oxybuprocaine is sold by Novartis under the brand names Novesine or Novesin. Safety for use in pregnancy and lactation has not been established. Contents 1 Uses 2 Pharmacokinetics 3 Adverse effects 4 Interactions 5 See also 6 References Uses In ophthalmology in order to numb the surface of the eye (the outermost layers of the cornea an...

Read more Fluress Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Oxybuprocaine

Recent Fluress Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Benoxinate + Fluorescein
  • Ointment: 0.4% + 0.25%
  • Solution: 0.4% + 0.25%
  • Solution/drops: 0.4% + 0.25%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Fluress: (1 result)

Sorted by National Drug Code
  • 17478-640 Fluress Ophthalmic Solution/ Drops by Akorn, Inc.

Drugs with one or more similar ingredients: (11 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA